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Summary Two hundred consecutive staging lymphadenectomies with metastatic prostate adenocarcinoma
and 100 consecutive autopsies with widely disseminated metastatic prostate adenocarcinoma were identified.
The metastases from 41% of the staging lymphadenectomies were entirely differentiated (gland forming) and
an additional 43% were predominantly (50% or more) differentiated. In contrast, the metastases from 70% of
the autopsies were entirely undifferentiated (non-gland forming) and an additional 18% were predominantly
undifferentiated. Further, five patients with completely or predominantly differentiated metastases in staging
lymphadenectomies were found to have widespread completely or predominantly undifferentiated metastases
at autopsy 4-7 years later. These findings suggest that dedifferentiation occurs within metastases and that
dedifferentiation within metastases may be important in understanding the widespread dissemination of
metastatic prostate carcinoma.
Dedifferentiation is characterised by a progression from a
more differentiated to a less differentiated histological
appearance with time. Dedifferentiation has been demon-
strated experimentally and clinically within primary tumours
but not, as yet, within metastases (Foulds, 1954; Kastendieck
& Altenahr, 1976; Nowell, 1976; Brawn, 1983; Barnett &
Eccles, 1984; Leonard & Smyth, 1985; Poste, 1986). In order
to determine whether dedifferentiation occurs within metas-
tases the current study compared the histology of metastatic
prostate carcinoma in staging lymphadenectomies to the
histology of widely disseminated prostate carcinoma at
autopsy.
Materials and methods
Eight hundred and fifty-seven consecutive staging lymphade-
nectomies were performed on patients with a diagnosis of
prostate carcinoma. Criteria for staging lymphadenectomy
were: (1) confirmed histological diagnosis of prostate carci-
noma in needle biopsy or transurethral resection of prostate;
(2) prostate carcinoma clinically confined to the prostate, or
6cm or less in size if extending beyond the capsule of the
prostate; and (3) no evidence of metastases preoperatively.
Two hundred of these 857 staging lymphadenectomies had
metastatic prostate carcinoma in pelvic lymph node(s)
(obturator, hypogastric, external iliac, internal iliac or
common iliac lymph nodes).
One hundred consecutive autopsies with widely dissemi-
nated metastatic prostate carcinoma were identified. Widely
disseminated metastatic prostate carcinoma was defined as
metastases beyond lymph nodes and/or bone. Invasions from
the prostate into adjacent tissue or organs were not con-
sidered to be metastases.
Metastases were determined to be of prostatic origin by:
(1) the histological appearance of the metastases; (2) a
comparison of the histological appearance of the primary
tumour and the metastases; (3) the gross description of the
prostate; and (4) serum acid phosphatase levels. If doubt
remained sections of the tumour were stained with a Prosta-
tic Specific Antigen Immunohistology kit (HistoGeMTM)
(Hadji et al., 1981).
The current study examined only prostate adenocarcinoma
and utilised Mostofi's (1975) observations, which categorise
prostate adenocarcinoma into differentiated and undifferen-
tiated histological patterns. Differentiated histological pat-
terns form malignant individual glands which may be large,
intermediate or small. Differentiated histological patterns
also form glands which may be cribriform, papillary or a
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mixture of cribriform and papillary (Figure 1). Undifferen-
tiated histological patterns do not form glands and may
occur in rows, in sheets or as individual cells (Figure 2).
Dedifferentiation was defined as a progression from a more
differentiated to a less differentiated histological appearance
with time.
The lymphadenectomy and autopsy metastases were exa-
mined microscopically to determine whether the metastases
were entirely or predominantly (50% or more) differentiated
or entirely or predominantly undifferentiated. This was a
Figure 1 Photomicrograph of differentiated (gland forming) cri-
briform metastatic prostate carcinoma from a pelvic lymph node
removed during staging lymphadenectomy (H&E x 100).
Figure 2 Photomicrograph of undifferentiated (non-gland form-
ing) metastatic prostate carcinoma from an autopsy with wide-
spread metastases (H&E x 100).
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Table I Characteristics of cases and histology of metastases
Race Histology of metastases
Entirely Predominantly Entirely Predominantly
Age range Average age White Black differentiated differentiated undifferentiated undifferentiated
Lymphadenectomy 49-74 62 151 49 41% 43% 4% 12%
cases
Autopsy 49-90 72 92 8 0% 12% 70% 18%
cases
simple determination somewhat similar to the M.D. Ander-
son method of grading prostate carcinoma (Brawn et al.,
1982). The M.D. Anderson grading system is similar struc-
turally to the Mayo method of grading prostate carcinoma
(Broders, 1932). The M.D. Anderson grading system divides
prostate adenocarcinomas into four grades: grade 1, 75-
100% of the tumour forms glands; grade 2, 50-75% of the
tumour forms glands; grade 3, 25-50% of the tumour forms
glands; grade 4, 0-25% of the tumour forms glands. The
M.D. Anderson method of grading prostate carcinoma was
designed to be a simple, low-power microscopic method that
reduces subjective grading criteria by requiring only that the
pathologist be able to determine the percentage of tumour
that forms glands and the percentage of tumour that does
not form glands. The M.D. Anderson method was used
without difficulty in the original study, which documented
dedifferentiation of prostate carcinoma (Brawn, 1983). The
task of determining whether metastases were entirely or
predominantly differentiated or were entirely or predomi-
nantly undifferentiated was less complicated than grading
prostate carcinoma. To underscore this simplicity the 200
lymphadenectomies and 100 autopsies were reviewed twice, 3
months apart, in a 'blinded' fashion. The second review
agreed with the classification of the first review in over 95%
of the lymphadenectomy and autopsy cases.
The number of patients with entirely or predominantly
differentiated metastases in the staging lymphadenectomies
were compared statistically to the number of autopsies with
entirely or predominantly differentiated metastases using the
x2 test, corrected for continuity.
Results
Table I details the age and race of the 200 lymphadenectomy
patients and the 100 autopsy cases, and the histology of the
lymphadenectomy metastases and the autopsy metastases. In
brief, 41% of metastases in staging lymphadenectomies were
entirely differentiated and an additional 43% were predomi-
nantly differentiated. No patients had metastases composed
entirely of individual malignant glands (Brawn & Johnson,
1987). In contrast, 70% of the widespread autopsy metas-
tases were entirely undifferentiated and an additional 18%
were predominantly undifferentiated. Table II details the
location and frequency of the metastases found at autopsy.
Table III compares the histology of the diagnostic
surgical/biopsy specimen to the histology of the respective
lymphadenectomy metastases, and the histology at autopsy
of the primary prostate carcinoma to the histology of the
widespread metastases. In brief, 73.5% of the surgical/biopsy
specimens had the same M.D. Anderson grade as the
lymphadenectomy metastases and 96% of the autopsies had
the same M.D. Anderson grade in the prostate as in the
widespread metastases. However, 21 of the 70 autopsies with
entirely undifferentiated widespread metastases had foci of
differentiated adenocarcinoma in the prostate. The differen-
tiated tumour in these 21 autopsies was not sufficient in
amount to alter the grade of the carcinoma.
The differences in the number of autopsies having entirely
or predominantly differentiated metastases compared to the
number of staging lymphadenectomies having entirely or
predominantly differentiated metastases was significant using
x2 (1 d.f.), corrected for continuity (P<0.001).
Nine of the 200 lymphadenectomies came to autopsy.
Table IV details the characteristics of these 9 cases. In brief,
at lymphadenectomy four of the nine cases had metastases
which were entirely differentiated and five had metastases
which were predominantly differentiated. At autopsy, two of
the nine cases had no evidence of metastases, two had
predominantly differentiated metastases confined to lymph
node or bone and five had widely disseminated metastases.
Three of these five cases had widely disseminated metastases
which were entirely undifferentiated and two had widely
disseminated metastases which were predominantly
undifferentiated.
Discussion
Staging lymphadenectomies for prostate carcinoma are per-
formed on patients with no evidence of metastases preopera-
tively. Survival data suggest that pelvic lymph nodes may be
one of the initial sites of metastatic prostate carcinoma since
some patients have apparently been cured of metastatic
prostate carcinoma after removal of pelvic lymph node
metastases (Scardino & Carlton, 1983). The current study
found that the metastases from 41% of staging lymphade-
nectomies were entirely differentiated (gland forming) and an
additional 43% were predominantly differentiated. In con-
trast, the metastases from 70% of autopsies with widespread
metastatic prostate carcinoma were entirely undifferentiated
(non-gland forming) and an additional 18% were predomi-
nantly undifferentiated.
There are several possible explanations why the initial
metastases from prostate carcinoma are differentiated while
widespread metastases are undifferentiated. It is possible that
therapy destroys the initial differentiated metastases. How-
ever, 19 of the 100 patients who came to autopsy were
diagnosed at autopsy and received no therapy. Forty-one of
the 100 patients who came to autopsy received limited
therapy consisting of a month or less of hormonal therapy
(oestrogen therapy or orchidectomy). The majority of the
remaining patients who came to autopsy received only
extended hormonal therapy. The patients receiving no ther-
apy, limited therapy or extended therapy had similar undif-
ferentiated metastases. Hormonal therapy has been reported
to cause various changes in prostate carcinomas, such as
Table II Frequency of metastatic sites
in 100 autopsies
Lymph nodes
Lung (including pleura)
Bone
Liver
Adrenal gland
Kidney
Brain (including
meninges and pituitary)
Spleen
Intestinal tract
Thyroid
Pancreas
Testis
Breast
Heart
Skin
Diaphragm
88
86
85
65
47
17
17
9
8
7
7
4
4
2
2
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Table III Comparison of histology in prostate and metastases
Surgical specimen Autopsy prostatea
versus versus
lymph node metastases widespread metastases
Similar histological pattern (same M.D.
Anderson grade-MDAH) 73 5% 96%b
Metastases more differentiated (one or
more MDAH grade difference) 9.5% 2%
Metastases less differentiated (one or
more MDAH grade difference) 16% 2%
aAvailable on 95 autopsies - 5 cases had prior radical prostatectomy; b 21% of the
prostates had areas of differentiated tumour not present in the widespread metastases. The
differentiated tumour was not sufficient in amount to alter the grade of the tumour.
Table IV Characteristics of nine patients who came
staging lymphadenectomy
to autopsy after
Histology of
Years to lymphadenectomy Histology of Radical
autopsy metastases autopsy metastases prostatectomy
I Entirely No metastases Yes
differentiated identified
3 Predominantly Predominantly No
differentiated differentiated
metastases in lymph
nodes and bone
4 Entirely No metastases No
differentiated identified
4 Predominantly Widespread entirely Yes
differentiated undifferentiated
5 Predominantly Widespread No
differentiated predominantly
undifferentiated
5 Predominantly Widespread Yes
differentiated predominantly
undifferentiated
6 Entirely Predominantly No
differentiated differentiated
metastases in lymph
nodes and bone
6 Entirely Widespread entirely Yes
differentiated undifferentiated
7 Predominantly Widespread entirely No
differentiated undifferentiated
nuclear pyknosis, cytoplasmic vacuolisation and stromal
fibrosis, but hormonal therapy has not been reported selec-
tively to destroy differentiated areas of tumour (Franks,
1960). Further, tumour necrosis, suggestive of tumour des-
truction secondary to therapy, was not a conspicuous feature
of any autopsy.
Another possibility is that undifferentiated metastases
directly from the prostate are responsible for the widespread
dissemination of metastatic prostate carcinoma. However, it
appears that metastases can disseminate without input from
the prostate. This concept is supported by the current study
which included three cases which had autopsies after com-
bined radical prostatectomy/staging lymphadenectomy.
These three cases had entirely or predominantly differen-
tiated metastases in the staging lymphadenectomies while the
disseminated metastases at autopsy were entirely or predomi-
nantly undifferentiated. It is possible that some of the
metastases in these three cases occurred before radical
prostatectomy. However, in view of the widespread dissemi-
nation of these metastases it is unlikely that this accounts for
all of the metastases. Further, the concept that metastases
metastasise is in accordance with the cascade theory of
metastases which has predicted that generalised metastases
(such as brain metastases) do not ordinarily occur directly
from the primary tumour (Viadana et al., 1978).
The current study provides no support for the concept
that differentiated metastases are restricted to pelvic lymph
nodes while undifferentiated metastases spread to other sites.
Autopsies with widespread metastases characteristically had
similar undifferentiated histological patterns in all metastatic
sites, including pelvic lymph nodes. Further, Butler et al.
(1971) studied 19 patients who presented with metastases in
enlarged supraclavicular lymph nodes as the initial presen-
tation of previously unrecognised prostate carcinoma. The
majority of the supraclavicular lymph node metastases were
differentiated, which indicates that differentiated metastases
are not restricted to pelvic lymph nodes.
It is unlikely that the inability to identify differentiated
histological patterns in widespread metastases was due to
sampling error. An average of 35 blocks of tissue were
examined per autopsy. One-half of the blocks were usually
from the prostate or from the metastases. The prostate not
infrequently contained undifferentiated and differentiated
histological patterns while the metastases characteristically
revealed a monotonous pattern of undifferentiated tumour.
It would be expected that differentiated histological patterns,
ifpresent in the widespread metastases, would be identified as
easily as they were identified in the prostate itself.
It could be argued that the patients who came to autopsy
represented a sub-population of patients with more aggress-
ive disease than the lymphadenectomy cases and therefore
were more likely to have undifferentiated patterns histologi-
cally. However, in the study of Butler et al. (1971) the
majority of the 19 cases had differentiated supraclavicular
lymph node metastases similar to the differentiated metas-
tases depicted in Figure 1 of the current study. These 19
patients were compared to a control group of 100 patients
who had prostate carcinoma but did not have a lymphade-
nectomy. The control group and the 19 patients had almost
identical median survivals of 2 years 8 months and 2 years
11 months. Butler's data suggest that patients undergoing
lymphadenectomy or patients whose initial lymph node
metastases are differentiated do not represent a subpopula-
tion of less aggressive prostate carcinoma.
Another explanation is that undifferentiated metastases
destroy differentiated metastases. However, prostate carcino-
mas typically consist of multiple histological patterns. It is
not widely believed that these histological patterns are in the
process of destroying one another. An alternative explana-
tion would be that a relative overgrowth of undifferentiated
elements and cell loss of the differentiated components
formed the undifferentiated patterns seen at autopsy. This
explanation does not necessitate the destruction of differen-
tiated metastases by undifferentiated metastases. However,
Butler's study suggests: (1) that differentiated metastases are
viable in locations other than pelvic lymph nodes; and (2)
that differentiated metastases may obtain enough tumour
bulk to enlarge supraclavicular lymph nodes. Consequently,
it is unlikely that differentiated metastases would be easily
overwhelmed or obscured by undifferentiated metastases.
The findings of the current study are most compatible
with the concept that metastases dedifferentiate with time.
The process of dedifferentiation has been demonstrated
clinically and experimentally within primary tumours
(Foulds, 1954; Kastendieck & Altenahr, 1976; Nowell, 1976;88 P.N. BRAWN & V.0. SPEIGHTS
Brawn, 1983; Barnett, 1984; Leonard & Smyth, 1985; Poste,
1986). It would not be unusual to expect a similar process to
occur within metastases. Dedifferentiation obviates the need
to hypothesise destruction of the initial differentiated metas-
tases. Rather than being destroyed the initial differentiated
metastases dedifferentiate and disseminate. Specific examples
of the process of dedifferentiation are found in the current
study, which identified five patients who had completely or
predominantly differentiated metastases in staging lymphade-
nectomies and had completely or predominantly undifferen-
tiated metastases at autopsy 4-7 years later.
The process of dedifferentiation presumably is a step by
step process. This step by step process explains why some
widespread metastases have residual differentiated histologi-
cal patterns while the majority of widespread metastases are
completely undifferentiated. The concept of histological
dedifferentiation within metastases has clinical significance in
that: (1) documenting the rapidity of dedifferentiation within
metastases may allow one to predict the rapidity of dis-
semination of metastatic disease; and (2) slowing or halting
dedifferentiation within metastases may control the dis-
semination of metastatic disease.
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